volume 27, issue 4, P781-790 2011
DOI: 10.3233/jad-2011-111046
View full text
Miryam Carecchio, Chiara Fenoglio, Francesca Cortini, Cristoforo Comi, Luisa Benussi, Roberta Ghidoni, Barbara Borroni, Milena De Riz, Maria Serpente, Claudia Cantoni, Massimo Franceschi, Valentina Albertini, Francesco Monaco, Innocenzo Rainero et al.

Abstract: Cerebrospinal fluid (CSF) biomarkers (Aβ₁₋₄₂, total tau, P-181 tau) are currently used to support a clinical diagnosis of Alzheimer's disease (AD). The CSF profile in frontotemporal lobar degeneration (FTLD) caused by Progranulin (GRN) mutation is unknown. We assessed CSF biomarkers in 145 AD, 140 FTLD (20 GRN positive, 120 GRN negative) patients, and 38 controls. Taking into account the reference values used in clinical practice, GRN mutation carriers and controls did not differ significantly for any biomarke…

expand abstract